Pharma criticizes new ban on advertising

Pharmaceutical companies do not agree with the new draft law extending the advertising ban to OTC pharmaceuticals containing the same substance or same combination of substances as the Rx pharmaceuticals. Ministry of Health suggested this change in the amendment to the Act on Pharmaceuticals. Pharmaceutical companies are protesting against it in the commentary round. The extended advertising ban would reportedly affect most of currently registered pharmaceuticals.